arrow
D

David M. Kaye

Alfred Hospital
H指数:103
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exercise stress echocardiography for diagnosis of heart failure with preserved ejection fraction: a multicentre study

运动负荷超声心动图对射血分数保留的心力衰竭的诊断:一项多中心研究

2026-09-100
PRE
Tissue-specific metabolomics in experimental HFpEF reveals hepatic remodelling modulated by SGLT2 inhibition

实验性HFpEF中的组织特异性代谢组学揭示受SGLT2抑制剂调控的肝脏重塑

2026-08-200
OA
Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-Controlled Device Trials: Insights From REDUCE LAP-HF II

在假手术对照器械试验中估计安慰剂效应对患者报告结局的影响:来自REDUCE LAP-HF II的见解

2026-01-011
PRE
A Pharmacokinetic Analysis of Intravenous Fluconazole in Adult Patients Undergoing Mechanical Circulatory Support Device Implantation

静脉氟康唑在成人机械循环支持装置植入患者中的药代动力学分析

2025-12-220
PRE
Long-term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials (Vol 278,pg 106, 2024)
2025-12-010
OAAI
The Impact of Crossing the Cervicothoracic Junction on Opioid Consumption, Readmission, and Revision Rates

跨越颈胸结合部对阿片类药物消耗、再入院率和翻修率的影响

2025-12-010
PRE
Long-Term Survival Advantage of Total Arterial Revascularization in Elderly Patients Following Coronary Artery Bypass Grafting

冠状动脉旁路移植术后老年患者中完全动脉再血管化的长期生存优势

2025-12-012
OAAI
Safety and performance of complex percutaneous coronary intervention in centres with and without on-site cardiac surgery: A multi-centre Australian study

复杂经皮冠状动脉介入治疗在有无现场心脏手术中心的安全性与疗效:一项多中心澳大利亚研究

2025-11-170
PRE
CD14 Blockade Modulates Macrophage-Mediated Immunological Injury in a Translational Model of Reperfused ST-Segment Elevation Myocardial Infarction

CD14阻断调节再灌注ST段抬高心肌梗死转化模型中的巨噬细胞介导的免疫损伤

2025-10-230
OAAI
Patient-Specific Haemodynamic Modeling to Estimate the Extent of Microvascular Disease and Response to Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension

基于患者特异性血流动力学建模,以评估慢性血栓栓塞性肺动脉高压患者微血管病变程度及肺动脉内膜剥脱术的响应。

2025-10-141
OAAI
Answer to the Letter to the Editor of A. Bilge, et al. concerning “Serotonin-norepinephrine reuptake inhibitor and gabapentinoid use independently predict greater postoperative opioid consumption in lumbar fusion patients” by Narayanan R, Dalton J, A McCurdy M, et al. (Eur Spine J [2025] doi:10.1007/s00586-025-08764-6)

针对A. Bilge等人关于“Narayanan R, Dalton J, A McCurdy M等人(Eur Spine J [2025] doi:10.1007/s00586-025-08764-6)发表的《5-羟色胺-去甲肾上腺素再摄取抑制剂和加巴喷丁类药物的使用独立预测腰椎融合患者术后阿片类药物消耗量增加”的致编辑信的回复。

2025-10-090
PRE
Effect of Cardiac Surgery Availability and Institutional Procedural Volume on Clinical Outcomes Following Complex, High-Risk, and Indicated Percutaneous Coronary Intervention
2025-10-010
PRE